Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/569
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorMARTIN, Patricia-
dc.contributor.authorTEODORO, Walcy R.-
dc.contributor.authorVELOSA, Ana Paula P.-
dc.contributor.authorMORAIS, Jymenez de-
dc.contributor.authorCARRASCO, Solange-
dc.contributor.authorCHRISTMANN, Romy B.-
dc.contributor.authorGOLDENSTEIN-SCHAINBERG, Claudia-
dc.contributor.authorPARRA, Edwin R.-
dc.contributor.authorKATAYAMA, Maria Lucia-
dc.contributor.authorSOTTO, Mirian N.-
dc.contributor.authorCAPELOZZI, Vera L.-
dc.contributor.authorYOSHINARI, Natalino H.-
dc.date.accessioned2013-07-30T14:43:49Z-
dc.date.available2013-07-30T14:43:49Z-
dc.date.issued2012-
dc.identifier.citationAUTOIMMUNITY REVIEWS, v.11, n.11, Special Issue, p.827-835, 2012-
dc.identifier.issn1568-9972-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/569-
dc.description.abstractObjective: The physiological and mechanical properties of the skin, the primary tissue affected by systemic sclerosis, depend on the assembly of collagen types I, Ill and V, which form heterotypic fibers. Collagen V (COLV) regulates heterotypic fiber diameter, and the maintenance of its properties is important for maintaining normal tissue architecture and function. Based on a COLV-induced experimental SSc model, in which overexpression of abnormal COLV was a prominent feature, we assumed that this abnormality could be present in SSc patients and could be correlated to disease duration, skin thickening and disease activity. Methods: Skin biopsies from 18 patients (6 early-stage and 12 late-stage) and 10 healthy controls were studied. Skin thickening assessment was performed with the Modified Rodnan Skin Score (MRSS), and activity was calculated using the Valentini Disease Activity Index. Morphology, morphometry of COLV deposition in dermis, as well as, quantitative RT-PCR and 3D-reconstruction of the dermal fibroblast culture were performed. Results: Structurally abnormal COLV was overexpressed in SSc skin, mainly in the early stages of the disease, when compared to normal controls and late-stage. A positive correlation between COLV expression and MRSS and disease activity was observed. Collagen V alpha-1 and alpha-2 mRNA expression levels were higher in SSc. Tridimensional reconstruction of SSc dermal heterotypic fibers confirmed the presence of atypical COLV. Conclusion: Increased synthesis of abnormal COLV and its correlation with disease stage, activity and MRSS suggest that this collagen can be a possible trigger involved in the pathogenesis of SSc.-
dc.description.sponsorshipFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)-
dc.description.sponsorshipFederico Foundation-
dc.language.isoeng-
dc.publisherELSEVIER SCIENCE BV-
dc.relation.ispartofAutoimmunity Reviews-
dc.rightsrestrictedAccess-
dc.subjectSystemic sclerosis-
dc.subjectType V collagen-
dc.subjectSkin-
dc.subjectModified Rodnan Skin Score-
dc.subjectValentini Disease Activity Index-
dc.subject.otherlung allograft-rejection-
dc.subject.otherbreast-cancer cells-
dc.subject.otherbronchiolitis obliterans-
dc.subject.otherpulmonary-fibrosis-
dc.subject.otherexperimental-model-
dc.subject.othernasal tolerance-
dc.subject.otheroral tolerance-
dc.subject.othergrowth-factor-
dc.subject.othert-cells-
dc.subject.otherscleroderma-
dc.titleAbnormal collagen V deposition in dermis correlates with skin thickening and disease activity in systemic sclerosis-
dc.typearticle-
dc.rights.holderCopyright ELSEVIER SCIENCE BV-
dc.identifier.doi10.1016/j.autrev.2012.02.017-
dc.identifier.pmid22406224-
dc.subject.wosImmunology-
dc.type.categoryreview-
dc.type.versionpublishedVersion-
hcfmusp.author.externalCHRISTMANN, Romy B.:Boston Univ, Sch Med, Boston, MA 02118 USA-
hcfmusp.description.beginpage827-
hcfmusp.description.endpage835-
hcfmusp.description.issue11-
hcfmusp.description.issueSpecial Issue-
hcfmusp.description.volume11-
hcfmusp.origemWOS-
hcfmusp.origem.id2-s2.0-84865356287-
hcfmusp.origem.idWOS:000308837500015-
hcfmusp.publisher.cityAMSTERDAM-
hcfmusp.publisher.countryNETHERLANDS-
hcfmusp.relation.referenceBehr J, 2008, RHEUMATOLOGY, V47, pV65, DOI 10.1093/rheumatology/ken313-
hcfmusp.relation.referenceBezerra MC, 2006, ARCH DERMATOL RES, V298, P51, DOI 10.1007/s00403-006-0645-5-
hcfmusp.relation.referenceBharat A, 2006, AM J TRANSPLANT, V6, P1799, DOI 10.1111/j.1600-6143.2006.01383.x-
hcfmusp.relation.referenceBIRK DE, 1990, J CELL SCI, V95, P649-
hcfmusp.relation.referenceBirk DE, 2001, MICRON, V32, P223, DOI 10.1016/S0968-4328(00)00043-3-
hcfmusp.relation.referenceBrinckmann J, 2005, MATRIX BIOL, V24, P459, DOI 10.1016/j.matbio.2005.07.002-
hcfmusp.relation.referenceCallado MRM, 2007, IMMUNOLOGY, V122, P38, DOI 10.1111/j.1365-2567.2007.02610.x-
hcfmusp.relation.referenceChanut-Delalande H, 2004, MOL CELL BIOL, V24, P6049, DOI 10.1128/MCB.24.13.6049-6057.2004-
hcfmusp.relation.referenceCLEMENTS P, 1995, J RHEUMATOL, V22, P1281-
hcfmusp.relation.referenceCoelho JC, 2000, GENET MOL BIOL, V23, P269-
hcfmusp.relation.referenceCorriveau MP, 2009, J PATHOL, V217, P534, DOI 10.1002/path.2482-
hcfmusp.relation.referenceCotton SA, 1999, J PATHOL, V189, P273, DOI 10.1002/(SICI)1096-9896(199910)189:2<273::AID-PATH413>3.3.CO;2-W-
hcfmusp.relation.referencede Oliveira CC, 2009, CLINICS, V64, P577, DOI 10.1590/S1807-59322009000600014-
hcfmusp.relation.referenceDerk CT, 2003, AUTOIMMUN REV, V2, P181, DOI 10.1016/S1568-9972(03)00005-3-
hcfmusp.relation.referenceFLEISCHMAJER R, 1978, ARTHRITIS RHEUM, V21, P418, DOI 10.1002/art.1780210404-
hcfmusp.relation.referenceGao MQ, 2010, J CELL SCI, V123, P3507, DOI 10.1242/jcs.072900-
hcfmusp.relation.referenceGelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002-
hcfmusp.relation.referenceHaque MA, 2002, J IMMUNOL, V169, P1542-
hcfmusp.relation.referenceHenkel W, 2007, J PROTEOME RES, V6, P4269, DOI 10.1021/pr070318r-
hcfmusp.relation.referenceJaramillo A, 1999, TRANSPLANTATION, V67, P1155, DOI 10.1097/00007890-199904270-00012-
hcfmusp.relation.referenceLaplante P, 2010, CELL DEATH DIFFER, V17, P291, DOI 10.1038/cdd.2009.124-
hcfmusp.relation.referenceLiu T, 2008, J HUAZHONG U SCI-MED, V28, P599, DOI 10.1007/s11596-008-0525-7-
hcfmusp.relation.referenceLuparello C, 2005, J CELL PHYSIOL, V202, P411, DOI 10.1002/jcp.20131-
hcfmusp.relation.referenceMalfait F, 2010, GENET MED, V12, P597, DOI 10.1097/GIM.0b013e3181eed412-
hcfmusp.relation.referenceMarangoni RG, 2011, ARTHRITIS RHEUM S, V62, pS253-
hcfmusp.relation.referenceMarangoni RG, 2010, CLIN EXP RHEUMATOL S, V5, P31-
hcfmusp.relation.referencePannu J, 2006, ARTHRITIS RHEUM, V54, P3011, DOI 10.1002/art.22063-
hcfmusp.relation.referenceParra ER, 2010, EUR J CLIN INVEST, V40, P110, DOI 10.1111/j.1365-2362.2009.02224.x-
hcfmusp.relation.referenceParra ER, 2009, CLIN RESPIR J, V3, P135, DOI 10.1111/j.1752-699X.2008.00118.x-
hcfmusp.relation.referenceQUINONES F, 1986, AM REV RESPIR DIS, V134, P1163-
hcfmusp.relation.referenceRIENTE L, 1995, CLIN EXP IMMUNOL, V102, P354-
hcfmusp.relation.referenceRoulet M, 2007, CELL TISSUE RES, V327, P323, DOI 10.1007/s00441-006-0294-1-
hcfmusp.relation.referenceSakkas LI, 2002, J IMMUNOL, V168, P3649-
hcfmusp.relation.referenceSakkas LI, 2004, ARTHRITIS RHEUM, V50, P1721, DOI 10.1002/art.20315-
hcfmusp.relation.referenceSargent JL, 2010, J INVEST DERMATOL, V130, P694, DOI 10.1038/jid.2009.318-
hcfmusp.relation.referenceSchmittgen TD, 2001, METHODS, V25, P402-
hcfmusp.relation.referenceSorrel MJ, 2004, J CELL PATHOL, V200, P134-
hcfmusp.relation.referenceSouza P, 2010, HUM PATHOL, V41, P239, DOI 10.1016/j.humpath.2009.07.018-
hcfmusp.relation.referenceSpiess K, 2007, CONNECT TISSUE RES, V48, P99, DOI 10.1080/03008200601166194-
hcfmusp.relation.referenceSubcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria, 1980, ARTHRITIS RHEUM, V23, P581-
hcfmusp.relation.referenceTeodoro WR, 2004, PATHOL RES PRACT, V200, P681, DOI 10.1016/j.prp.2004.05.007-
hcfmusp.relation.referenceValentini G, 2003, CLIN EXP RHEUMATOL, V21, pS39-
hcfmusp.relation.referenceVelosa APP, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-1-
hcfmusp.relation.referenceVelosa APP, 2007, ARCH DERMATOL RES, V299, P177, DOI 10.1007/s00403-007-0735-z-
hcfmusp.relation.referenceWells AU, 2008, RHEUMATOLOGY, V47, pV59, DOI 10.1093/rheumatology/ken271-
hcfmusp.relation.referenceWHITE B, 1995, ARTHRITIS RHEUM, V38, P351, DOI 10.1002/art.1780380309-
hcfmusp.relation.referenceWigley FM, 2003, RHEUMATOLOGY, P1463-
hcfmusp.relation.referenceYasufuku K, 2002, TRANSPLANTATION, V73, P500, DOI 10.1097/00007890-200202270-00002-
hcfmusp.relation.referenceYasufuku K, 2001, AM J RESP CELL MOL, V25, P26-
dc.description.indexMEDLINE-
hcfmusp.remissive.sponsorshipFAPESP-
hcfmusp.remissive.sponsorshipFederico Foundation-
hcfmusp.remissive.sponsorshipFAPESP-
hcfmusp.remissive.sponsorshipFederico Foundation-
hcfmusp.lim.ref2012-
hcfmusp.citation.scopus47-
hcfmusp.scopus.lastupdate2024-03-29-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MCM
Departamento de Clínica Médica - FM/MCM

Artigos e Materiais de Revistas Científicas - FM/MDR
Departamento de Radiologia - FM/MDR

Artigos e Materiais de Revistas Científicas - FM/MDT
Departamento de Dermatologia - FM/MDT

Artigos e Materiais de Revistas Científicas - FM/MPT
Departamento de Patologia - FM/MPT

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - LIM/17
LIM/17 - Laboratório de Investigação em Reumatologia

Artigos e Materiais de Revistas Científicas - LIM/24
LIM/24 - Laboratório de Oncologia Experimental

Artigos e Materiais de Revistas Científicas - LIM/53
LIM/53 - Laboratório de Micologia


Files in This Item:
File Description SizeFormat 
art_MARTIN_Abnormal_collagen_V_deposition_in_dermis_correlates_with_2012.PDF
  Restricted Access
publishedVersion (English)1.71 MBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.